Education
About Us
Working with TipRanks
Follow Us
Dr. Reddy's Laboratories Ltd. (IN:DRREDDY)
:DRREDDY
Total Valuation
Dr. Reddy's Laboratories Ltd. has a market cap or net worth of ₹973.45B. The enterprise value is ₹1.06T.
Market Cap₹973.45B
Enterprise Value₹1.06T
Share Statistics
Dr. Reddy's Laboratories Ltd. has 834,591,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding834,591,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 13.34%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.11
Return on Invested Capital (ROIC)13.34%
Return on Capital Employed (ROCE)0.20
Revenue Per Employee12.04M
Profits Per Employee2.09M
Employee Count27,048
Asset Turnover0.66
Inventory Turnover1.90
Valuation Ratios
The current PE Ratio of Dr. Reddy's Laboratories Ltd. is 17.0. Dr. Reddy's Laboratories Ltd.’s PEG ratio is 11.98.
PE Ratio17.0
PS Ratio2.95
PB Ratio2.88
Price to Fair Value2.88
Price to FCF50.79
Price to Operating Cash Flow17.28
PEG Ratio11.98
Income Statement
In the last 12 months, Dr. Reddy's Laboratories Ltd. had revenue of 325.54B and earned 56.54B in profits. Earnings per share was 67.88.
Revenue325.54B
Gross Profit190.43B
Operating Income71.84B
Pretax Income76.78B
Net Income56.54B
EBITDA88.84B
Earnings Per Share (EPS)67.88
Cash Flow
In the last 12 months, operating cash flow was 62.53B and capital expenditures -34.65B, giving a free cash flow of 27.88B billion.
Operating Cash Flow62.53B
Free Cash Flow27.88B
Free Cash Flow per Share33.41
Dividends & Yields
Dr. Reddy's Laboratories Ltd. pays an annual dividend of ₹8, resulting in a dividend yield of 0.63%
Dividend Per Share₹8
Dividend Yield0.63%
Payout Ratio11.38%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change-5.00%
50-Day Moving Average1.24K
200-Day Moving Average1.25K
Relative Strength Index (RSI)49.17
Average Volume (3m)225.11K
Important Dates
Dr. Reddy's Laboratories Ltd. upcoming earnings date is May 8, 2026, Before Open (Confirmed).
Last Earnings DateJan 21, 2026
Next Earnings DateMay 8, 2026
Ex-Dividend Date―
Financial Position
Dr. Reddy's Laboratories Ltd. as a current ratio of 1.92, with Debt / Equity ratio of 16.33%
Current Ratio1.92
Quick Ratio1.37
Debt to Market Cap0.05
Net Debt to EBITDA0.36
Interest Coverage Ratio25.40
Taxes
In the past 12 months, Dr. Reddy's Laboratories Ltd. has paid 19.54B in taxes.
Income Tax19.54B
Effective Tax Rate0.25
Enterprise Valuation
Dr. Reddy's Laboratories Ltd. EV to EBITDA ratio is 11.18, with an EV/FCF ratio of 52.49.
EV to Sales3.05
EV to EBITDA11.18
EV to Free Cash Flow52.49
EV to Operating Cash Flow21.39
Balance Sheet
Dr. Reddy's Laboratories Ltd. has ₹82.59B in cash and marketable securities with ₹79.34B in debt, giving a net cash position of ₹3.25B billion.
Cash & Marketable Securities₹82.59B
Total Debt₹79.34B
Net Cash₹3.25B
Net Cash Per Share₹3.89
Tangible Book Value Per Share₹273.97
Margins
Gross margin is 56.43%, with operating margin of 22.07%, and net profit margin of 17.37%.
Gross Margin56.43%
Operating Margin22.07%
Pretax Margin23.59%
Net Profit Margin17.37%
EBITDA Margin27.29%
EBIT Margin22.43%
Analyst Forecast
The average price target for Dr. Reddy's Laboratories Ltd. is ₹1,425.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,425.00
Price Target Upside11.29% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast14.10%
EPS Growth Forecast9.72%